Similar Items: Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities
- Repurposing Resmetirom to Suppress MASLD/MASH-HCC in the Dysmetabolic Era
- Heterogeneity of Cancer‐Associated Fibroblasts and Precision Targeting Strategies for Cancer Therapy
- Antidiabetic agents as potential cytotoxic candidates for cancer therapy
- ADPB Sensitivity in Breast Cancer is Correlated with LAT1 Expression: An in vitro Study of a Novel Theranostic Candidate
- Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution
- Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives